Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Harvard Apparatus Regenerative Technology (HRGN)
OTHER OTC:HRGN
Harvard Apparatus Regenerative Technology (HRGN) Stock Price & Analysis
101 Followers
HRGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.13 - $6.00
Previous Close$2.58
Volume107.00
Average Volume (3M)21.08K
Market Cap
$36.86M
Enterprise Value$36.48M
Total Cash (Recent Filing)$432.00K
Total Debt (Recent Filing)$48.00K
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding14,315,091
10 Day Avg. Volume57,314
30 Day Avg. Volume21,079
Standard Deviation0.25
R-Squared0.08
Alpha0.04
Financial Highlights & Ratios
Price to Book (P/B)13.81
Price to Sales (P/S)614.85
Price to Cash Flow (P/CF)-3.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue354.15
Enterprise Value/Gross Profit461.74
Enterprise Value/Ebitda-12.05
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Harvard Apparatus Regenerative Technology News
Ownership Overview
93.45% Insiders
0.00% Mutual Funds
0.09% Other Institutional Investors
6.45% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
HRGN FAQ
What was Harvard Apparatus Regenerative Technology’s price range in the past 12 months?
Harvard Apparatus Regenerative Technology lowest stock price was $2.13 and its highest was $6.00 in the past 12 months.
What is Harvard Apparatus Regenerative Technology’s market cap?
Currently, no data Available
When is Harvard Apparatus Regenerative Technology’s upcoming earnings report date?
Harvard Apparatus Regenerative Technology’s upcoming earnings report date is Aug 13, 2024 which is in 15 days.
How were Harvard Apparatus Regenerative Technology’s earnings last quarter?
Currently, no data Available
Is Harvard Apparatus Regenerative Technology overvalued?
According to Wall Street analysts Harvard Apparatus Regenerative Technology’s price is currently Overvalued.
Does Harvard Apparatus Regenerative Technology pay dividends?
Harvard Apparatus Regenerative Technology does not currently pay dividends.
What is Harvard Apparatus Regenerative Technology’s EPS estimate?
Harvard Apparatus Regenerative Technology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Harvard Apparatus Regenerative Technology have?
Harvard Apparatus Regenerative Technology has 14,315,091 shares outstanding.
What happened to Harvard Apparatus Regenerative Technology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Harvard Apparatus Regenerative Technology?
Currently, no hedge funds are holding shares in HRGN
---
Harvard Apparatus Regenerative Technology Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-37.19%
12-Months-Change
Fundamentals
Return on Equity
-511.06%
Trailing 12-Months
Asset Growth
-44.30%
Trailing 12-Months
Company Description
Harvard Apparatus Regenerative Technology
Biostage, Inc. is a biotechnology company, which engages in the development of organ implants to treat congenital defects, cancers, and life-threatening conditions of the esophagus, bronchus and trachea. It operates through Cellframe technology, engineered to stimulate the body's signaling pathways and natural healing process to regenerate and restore organ function. The company was founded on May 3, 2012 and is headquartered in Holliston, MA.
---
Technical Analysis
---